Other papers submitted by: Dr Samuela Castelnuovo

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Samuela Castelnuovo

Paper published by Dr Samuela Castelnuovo:

Review

Noteworthy comment: The new anti-PCSK9 monoclonal antibodies, with profound abilities to lower LDL-C as well as lipoprotein (a), may be on the verge of ushering in a new era in cardiovascular risk management. This review contains much information about this new class of drugs, and is highly recommended.

Highly-accessed

Potential of PCSK9 as a new target for the management of LDL cholesterol

Mombelli G, Castelnuovo S, Pavanello C

Research Reports in Clinical Cardiology 2015, 6:73-86

Published Date: 15 July 2015